Search fresh public links, source activity, and post angles for Weight Loss Medications.
Fresh curated links around weight loss medications are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
An authoritative look at current FDA-approved weight loss medications, their brands and results, and how obesity intersects with disability
There is a misunderstanding that has taken hold in how people speak about the popular “weight loss” medications like Ozempic and Wegovy. They are often described as drugs that caus...
The U.S. Food and Drug Administration has approved a new GLP-1 for weight loss, adding a new once-daily pill to the pharmaceutical competition over the popular drugs.
The U.S. Food and Drug Administration has approved a new GLP-1 for weight loss, adding a new once-daily pill to the pharmaceutical competition over the popular drugs.
Bariatric surgery and GLP-1 medications like Wegovy and Zepbound are the two most effective ways to shed pounds.A recent JAMA study shows both methods dramatically cut body fat wit...
In recent years, discussions around weight management have evolved beyond fad diets and temporary fixes. Modern weight loss medications are increasingly recognized as clinically su...
From GLP-1s to weight-loss pills, there are plenty of medications promising to help us reach our health goals. Enter phentermine, a prescription weight-loss pill for short-term use...
Imagine shedding pounds like you just had gastric bypass—without the surgery. That’s the buzz around Eli Lilly’s new weight loss contender. Continue reading…
FRIDAY, May 8, 2026 (Health Day News) — Starting in July, Medicare beneficiaries may be able to get a GLP-1 prescription for weight loss for $50 a month. It’s a notable shift for M...
WEDNESDAY, May 6, 2026 — The number of weight-loss surgery procedures in the United States is dropping rapidly in the face of cutting-edge drugs like Ozempic and Zepbound, a new st...
Eli Lilly’s highly anticipated new weight loss drug, retatrutide, helped people lose up to 30% of their body weight, about 85 pounds, in a late-stage clinical trial, the drugmaker...
Experimental drug retatrutide cut weight by nearly 30% in Phase 3 trials, outperforming approved therapies, Eli Lilly says.
GLP-1 weight loss medications such as Ozempic®, Wegovy®, Mounjaro®, and Zepbound™ have transformed the way we approach weight loss and metabolic health. These treatments mimic...
The FDA has approved a pill from Eli Lilly that could change how millions of Americans take medications to lose weight. The drug is the second GLP-1 pill approved by federal regula...
People who got the injection, retatrutide, lost 28 percent of their body weight on average after 80 weeks, Eli Lilly said.
The meds arrived with considerable fanfare. Semaglutide, tirzepatide, the whole GLP-1 family: drugs that could, apparently, do something medicine had never managed well before. Shr...
The U.S. Food and Drug Administration on Wednesday approved the second GLP-1 pill for weight loss, adding another option to a rapidly growing arsenal of obesity therapies.
Among seniors with diagnosed diabetes, roughly 20.8% are using GLP-1 injectables. It is a key part of addressing their health concerns. While the weight loss...
The U.S. Food and Drug Administration on Wednesday approved Eli Lilly's weight-loss pill, making it the second to market after Novo Nordisk's oral Wegovy, as the companies fight to...
The Food and Drug Administration's decision Wednesday means patients in the United States will soon have access to a second daily oral medication to treat obesity and weight-relate...
Weight loss culture is shifting again. In recent years, the dominant aesthetic ideal emphasized curves and the “Kardashian-curve” look popularized across social media. Today, the p...
The U.S. Food and Drug Administration on Wednesday approved the second GLP-1 pill for weight loss, adding another option to a rapidly growing arsenal of obesity therapies.
SEATTLE — Demand for weight-loss drugs is ballooning across the United States, and Amazon wants in. The Seattle-based tech giant launched its own GLP-1 program Tuesday aimed at str...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.